Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. DYSPORT
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DYSPORT

Medicine - Posted on May 22 2023
Active substance (DCI)
  • toxine botulinique type A
history (5)
  • 5/10/23

    DYSPORT 500 UNITES SPEYWOOD (toxine botulinique type A) - Blépharospasme, spasme hémifacial, torticolis spasmodique

    Réévaluation. L'essentiel Avis favorable au maintien du remboursement dans le blépharospasme, le spasme hémifacial et le tor...
    icône flèche
  • 11/23/22

    DYSPORT 300 et 500 UNITES SPEYWOOD (toxine botulinique de type A) - Incontinence urinaire

    Key points Approval of reimbursement for the indication “treatment of urinary incontinence in adults with neurogenic detruso...
    CAV :
    54321
    icône flèche
  • 9/16/20

    DYSPORT

    Key points Favourable opinion for reimbursement in the local symptomatic treatment of spasticity of the upper limbs in child...
    CAV :
    54321
    icône flèche
  • 11/7/12

    DYSPORT

    -
    CAV :
    54321
    icône flèche
  • 9/6/06

    DYSPORT

    DYSPORT
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • M03AX01
Manufacturer
IPSEN PHARMA
Presentation

DYSPORT 300 UNITES SPEYWOOD, poudre pour solution injectable
1 flacon en verre (CIP : 34009 577 649 0 6)

DYSPORT 500 UNITES SPEYWOOD, poudre pour solution injectable
1 flacon en verre (CIP : 34009 558 105 9 9)

All our publications
    Drug therapy Eye diseases Mouth diseases Musculoskeletal diseases - miscellaneous Neuromuscular diseases Urination disorders

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
mJu56eyq7q3taPH3